Commercial interests, transparency, and independence: a call for submissions
A decade ago the US Institute of Medicine (IOM) issued a landmark report on conflicts of interest in research, medical education, and practice.1 Highlighting benefits of collaborations between physicians, researchers, and companies to develop new products that can improve health, the report also raised substantial concerns that extensive financial ties could unduly influence professional judgments. It concluded these financial conflicts of interest could jeopardise the integrity of science, the objectivity of education, the quality of care, and public trust in medicine. The report recommended more research on conflicts of interest, improvements in transparency, and greater independence from industry.
Para acceder al sitio, haga [kleo_button title=»Clic Aquí» href=»https://www.bmj.com/content/365/bmj.l1706″ style=»default» size=»» target=»_blank»]